Dana–Farber Cancer Institute - PDFSEARCH.IO - Document Search Engine

Dana–Farber Cancer Institute
Results: 211

#	Item
31	Membership Dana-Farber/Harvard Cancer Center is the largest cancer research consortium in the nation, and receives more than $500 million in cancer-related funding each year. DF/HCC’s more than 1,000 members hold Harva Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2015-02-05 19:49:58 Harvard University Dana–Farber/Harvard Cancer Center Biotechnology Laboratories Dana–Farber Cancer Institute NCI-designated Cancer Center Beth Israel Deaconess Medical Center Cancer research William K. Oh Medicine Cancer organizations Harvard Medical School
32	DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Training Requirements for DF/HCC Sponsors and new DF/HCC Sponsor Team Personnel of DF/HCC Multi-Center Trials SOP #: MUL Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2014-09-18 14:57:14 Clinical research Pharmaceutical industry Pharmacology Dana–Farber Cancer Institute Harvard Medical School Clinical trial Investigational Device Exemption Regulatory requirement Food and Drug Administration Research Medicine Pharmaceutical sciences
33	INSTITUTE FOR INTERNATIONAL LAW & HUMAN RIGHTS OVERVIEW OF RESEARCH INSTITUTES AUGUSTPREPARED BY Add to Reading List Source URL: lawandhumanrights.org Language: English - Date: 2015-01-19 16:02:31 Cancer research Oncology War on Cancer National Cancer Institute National Research Council Office of Cancer Complementary and Alternative Medicine Dana–Farber/Harvard Cancer Center Medicine Cancer organizations National Institutes of Health
34	Human Kinase Open Reading Frame Collec6on Description: The Center for Cancer Systems Biology (Dana Farber Cancer Institute)Broad Institute of Harvard and MIT Human Kinase ORF collection from Addgene consists of Add to Reading List Source URL: www.addgene.org Language: English - Date: 2014-11-05 23:32:08 Protein kinases Cell cycle Molecular biology Tyrosine kinase receptors Plasmid TIE1 Cyclin-dependent kinase AKT Mitogen-activated protein kinase Biology Cell biology Proteins
35	Institutional Decision Makers Disclosures: Dr. Ronald DePinho, President Before joining The University of Texas MD Anderson Cancer Center in 2011, Dr. Ronald DePinho, President, and his wife, Dr. Lynda Chin, MD Anderson Add to Reading List Source URL: www.mdanderson.org Language: English - Date: 2015-05-05 07:31:38 University of Texas MD Anderson Cancer Center Dana–Farber Cancer Institute Health Farber Monroe Dunaway Anderson Cancer organizations Medicine Ronald A. DePinho
36	DANA-FARBER / HARVARD CANCER CENTER Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-07-02 10:42:11 Medicine Health Auditing Design of experiments Pharmacology Clinical trial Dana–Farber Cancer Institute Institutional review board Investigational New Drug Clinical research Research Pharmaceutical industry
37	DANA-FARBER / HARVARD CANCER CENTER Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-07-02 10:39:23 Medicine Pharmacology Pharmaceutical industry Design of experiments Dana–Farber Cancer Institute Standard operating procedure Clinical trial LISTSERV Food and Drug Administration Clinical research Research Science
38	Office of Medical Affairs and Professional Credentialing Dana-Farber Cancer Institute, CP315 44 Binney Street Boston, MAtel, fax Add to Reading List Source URL: www.dfhcc.harvard.edu - Date: 2011-08-31 17:02:21
39	Bridge Project 2014_RFA_FINAL Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2014-05-09 11:53:43 Cancer research Association of Independent Technological Universities Massachusetts Institute of Technology New England Association of Schools and Colleges Dana–Farber Cancer Institute National Institutes of Health Medicine Health Cancer organizations
40	ACRONYMS AE Adverse Event BIDMC Add to Reading List Source URL: www.dfhcc.harvard.edu Language: English - Date: 2012-10-12 15:20:44 Clinical research Pharmaceutical industry Food and Drug Administration Pharmacology Medical statistics Clinical trial Investigational Device Exemption Investigational New Drug Dana–Farber Cancer Institute Health Research Medicine

UPDATE